Research

We analyze regulatory incentives, funding and reimbursement of breakthrough medical innovation such as novel gene therapies and CAR-T cell therapy. We study the dissemination of digital health technologies, e.g. the widespread use of mHealth devices for detecting atrial fibrillation or telemedicine in surgery. We analyze the determinants of cultivating a successful entrepreneurship culture for medical innovation and what sets one country apart from another.

With our international partners, we analyze successful incentives for foreign direct investments in the health care sector. During the Covid-19 pandemic, we compared the performance and preparedness of international health care systems and its impact on resource allocation.

Open Access

Economic and Environmental Impact of Digital Health App Video Consultations in Follow-up Care for Patients in Orthopedic and Trauma Surgery in Germany: Randomized Controlled Trial 

Motion Artifact Reduction in Electrocardiogram Signals Through a Redundant Denoising Independent Component Analysis Method for Wearable Health Care Monitoring Systems: Algorithm Development and Validation

COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany – A claims data analysis 

Assessing Telemedicine Efficiency in Follow-up Care With Video Consultations for Patients in Orthopedic and Trauma Surgery in Germany: Randomized Controlled Trial

COVID-19 pandemic and waiting times in outpatient specialist care in Germany: an empirical analysis

Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany

Factors Influencing Mortality during the COVID-19 Pandemic

Accuracy of mHealth Devices for Atrial Fibrillation Screening: Systematic Review

Contact Prof. Christian Gissel, Licher Strasse 62, 35394 Giessen, Germany, +49 641 99 22070, cg@phec.de